Research Center Profile:
Advanced Pharma CR
Samantha AmabaPresident & CEOAdvanced Pharma CRUniverisity of Miami Life Science & Technology Park
1951 NW 7th Avenue
Suite 450Miami, FL 33136USA305-220-2727305-220-2730 (fax)firstname.lastname@example.orgView MapContact Center
Currently Enrolling Trials
Hepatology (Liver, Pancreatic, Gall Bladder)
Nutrition and Weight Loss
"First in Man to Market"
Advanced Pharma CR (APCR) is a dedicated Phase I Clinical Research Facility. We are located within the City of Miami’s Health District, the second largest in the nation, in the architecturally “green” University of Miami Life Science and Technology Park. Our location bolsters our relationships with many specialists and subspecialists and serves as a magnet for attracting a high volume of volunteers, while providing a state-of-the-art facility for pharmaceutical, biotech, and medical device industries.
APCR provides pharmaceutical, biotech, and medical device companies with a state-of-the-art, 25,000 square feet facility that houses 150 beds, which includes two (16 bed and 24 bed) Intensive Procedure Units (IPUs).
APCR’s principals have participated in Phase I clinical trials since 1992. Advanced Pharma’s Executive Medical Director Dr. Gilbert R. Weiner, DO, AOBFP, CPI is board certified in Family Practice and has been practicing medicine since 1967. As a Certified Physician Investigator, Dr. Weiner has participated in over 500 Phase I clinical trials. Dr. Weiner and the rest of our team have 50-plus years of combined research experience in over 1,000 Phase I trials. Our multi-specialty physician investigators enable APCR to engage in multiple aspects of Phase I pharmaceutical, biotech, and medical device trials.
Our historical volunteer data confirms that we have outstanding recruitment, enrollment, and retention statistics. We retain a robust database of over 10,000 volunteers. APCR exceeds industry standards for enrollment requirements and trial completion percentages.
Phase I Trial Experience: Healthy Volunteers
Phase I Trial Experience: Special Populations
Route Administration Experience
In addition to the Phase I experience listed above, we serve ALL Specialties and ALL Indications.
Late Phase Development
Clinical Research Experience
Throughout the years, our experienced research team has participated in clinical trials working directly with the following Sponsors/CRO's:
Our current operations include a 25 bed dedicated Phase I Unit. Expansion to 25,000 square feet is underway. Upon completion of the build-out in November 2012, we will house 150 beds, which will include two (16 bed and 24 bed) Intensive Procedure Units (IPUs).
Clinical Trial Services
Advanced Pharma includes the following departments, each with its own dedicated staff of skilled, appropriately trained and certified professionals.
Our facility has the following areas and features:
President & CEO
Samantha Amaba began participating in research in 1992, when she took part in Cardiology Device Research at a large teaching hospital in Memphis, TN. After acquiring a wealth of research experience, Samantha relocated to South Florida where she became involved in Pharmaceutical Research, in particular managing Phase I-IV Clinical Trials. She has substantial management experience in Special Populations as well. Samantha has demonstrated exceptional ability to direct multiple million-dollar trials with complete satisfaction from clients.
Through the years, Samantha has maintained an excellent relationship and reputation within the pharmaceutical industry. Her passion for Clinical Research has proven to be the avenue to her success!
Ivette Lopez, CCRC
Vice President & COO
Key Members of APCR
Gilbert Weiner, DO, AOBFP, CPI
Medical Director - Principal Investigator
Terrye Thomas, RPh
Associate Director, Pharmacy
Advanced Pharma CR uses a local/central IRB, Independent IRB, and we are also willing to work with an IRB of your choosing.
If you are interested in contacting this center to discuss placing a clinical
trial there, please complete and send the email form below. A representative from
the research center will then follow up with you.
Unless otherwise specified, all medical content is compiled by MSF staff and reviewed for accuracy by a member of our Medical Advisory Board.
The MSF strives to present clear and unbiased information. This site is partially funded through a grant from Bayer Healthcare, LLC.
© Copyright 2000-2009 Multiple Sclerosis Foundation - All Rights Reserved